These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

229 related articles for article (PubMed ID: 36300672)

  • 1. Relationship of advanced glycation end-products in hypertension in diabetic patients: a systematic review.
    Fuhr JC; Ramos MEK; Piovesan F; Renner LO; Siqueira LO
    J Bras Nefrol; 2022; 44(4):557-572. PubMed ID: 36300672
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Advanced Glycation End Products and Their Effect on Vascular Complications in Type 2 Diabetes Mellitus.
    Lee J; Yun JS; Ko SH
    Nutrients; 2022 Jul; 14(15):. PubMed ID: 35956261
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Advanced glycation end products as biomarkers for cardiovascular disease: browning clarifying atherogenesis.
    Pinto RS; Machado UF; Passarelli M
    Biomark Med; 2020 Jun; 14(8):611-614. PubMed ID: 32530293
    [No Abstract]   [Full Text] [Related]  

  • 4. A Glycation Angle to Look into the Diabetic Vasculopathy: Cause and Cure.
    Ahmad S; Siddiqui Z; Rehman S; Khan MY; Khan H; Khanum S; Alouffi S; Saeed M
    Curr Vasc Pharmacol; 2017; 15(4):352-364. PubMed ID: 28356033
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Recent progress in advanced glycation end products and diabetic complications.
    Vlassara H
    Diabetes; 1997 Sep; 46 Suppl 2():S19-25. PubMed ID: 9285494
    [No Abstract]   [Full Text] [Related]  

  • 6. Inhibition of advance glycation end products formation, gastrointestinal digestion, absorption and toxicity: A comprehensive review.
    Feng N; Feng Y; Tan J; Zhou C; Xu J; Chen Y; Xiao J; He Y; Wang C; Zhou M; Wu Q
    Int J Biol Macromol; 2023 Sep; 249():125814. PubMed ID: 37451379
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Activation of RAGE-dependent endoplasmic reticulum stress associates with exacerbated postmyocardial infarction ventricular arrhythmias in diabetes.
    Liu Z; Zhang Y; Pan S; Qiu C; Jia H; Wang Y; Zhu H
    Am J Physiol Endocrinol Metab; 2021 Mar; 320(3):E539-E550. PubMed ID: 33459180
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Immunomodulation by Processed Animal Feed: The Role of Maillard Reaction Products and Advanced Glycation End-Products (AGEs).
    Teodorowicz M; Hendriks WH; Wichers HJ; Savelkoul HFJ
    Front Immunol; 2018; 9():2088. PubMed ID: 30271411
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Sex disparity in cardiovascular mortality rates associated with diabetes.
    Yamagishi SI
    Diabetes Metab Res Rev; 2018 Nov; 34(8):e3059. PubMed ID: 30098301
    [No Abstract]   [Full Text] [Related]  

  • 10. Revisiting Methodologies for In Vitro Preparations of Advanced Glycation End Products.
    Sahi AK; Verma P; Varshney N; Gundu S; Mahto SK
    Appl Biochem Biotechnol; 2022 Jun; 194(6):2831-2855. PubMed ID: 35257316
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Age-Influenced Receptors of Advanced Glycation End Product Overexpression Associated With Osteogenic Differentiation Impairment in Patients With Type 2 Diabetes.
    Phimphilai M; Pothacharoen P; Kongtawelert P
    Front Endocrinol (Lausanne); 2021; 12():726182. PubMed ID: 34512554
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Advanced Glycation End Products: Potential Mechanism and Therapeutic Target in Cardiovascular Complications under Diabetes.
    Yang P; Feng J; Peng Q; Liu X; Fan Z
    Oxid Med Cell Longev; 2019; 2019():9570616. PubMed ID: 31885827
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The receptor for advanced glycation end-products has a central role in mediating the effects of advanced glycation end-products on the development of vascular disease in diabetes mellitus.
    Hori O; Yan SD; Ogawa S; Kuwabara K; Matsumoto M; Stern D; Schmidt AM
    Nephrol Dial Transplant; 1996; 11 Suppl 5():13-6. PubMed ID: 9044300
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Expression of advanced glycation end products and their receptors in diabetic periodontitis patients.
    Thomas JT; Joseph B; Sorsa T; Mauramo M; Anil S; Waltimo T
    Oral Dis; 2024 Jul; 30(5):2784-2796. PubMed ID: 37891010
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Protective role of sulphoraphane against vascular complications in diabetes.
    Yamagishi S; Matsui T
    Pharm Biol; 2016 Oct; 54(10):2329-39. PubMed ID: 26841240
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Advanced Glycation End Products: A Molecular Target for Vascular Complications in Diabetes.
    Yamagishi S; Nakamura N; Suematsu M; Kaseda K; Matsui T
    Mol Med; 2015 Oct; 21 Suppl 1(Suppl 1):S32-40. PubMed ID: 26605646
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Advanced Glycation End Products, Diabetes, and Bone Strength.
    Yamamoto M; Sugimoto T
    Curr Osteoporos Rep; 2016 Dec; 14(6):320-326. PubMed ID: 27704396
    [TBL] [Abstract][Full Text] [Related]  

  • 18.
    López-Díez R; Shen X; Daffu G; Khursheed M; Hu J; Song F; Rosario R; Xu Y; Li Q; Xi X; Zou YS; Li H; Schmidt AM; Yan SF
    Arterioscler Thromb Vasc Biol; 2017 Aug; 37(8):1536-1547. PubMed ID: 28642238
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Phytochemicals as Potential Inhibitors of Advanced Glycation End Products: Health Aspects and Patent Survey.
    Fernandes ACF; Melo JB; Genova VM; Santana ÁL; Macedo G
    Recent Adv Food Nutr Agric; 2022 Nov; 13(1):3-16. PubMed ID: 34053432
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Advanced glycation endproducts and diabetes. Beyond vascular complications.
    Puddu A; Viviani GL
    Endocr Metab Immune Disord Drug Targets; 2011 Jun; 11(2):132-40. PubMed ID: 21476962
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.